Galenica AG
Swiss Stock Exchange:GALE.SW
Sector
Location
Market Cap
USD 5.32 B
Share Price
USD 106.75
Avg Daily Volume
96,322
Change (1 day)
-1.99%
Change (1 year)
23.03%
Change (YTD)
29.84%
Galenica AG Return on Capital Employed (ROCE) for the year ending December 31, 2024: 9.47%
Galenica AG Return on Capital Employed (ROCE) is 9.47% for the year ending December 31, 2024, a 3.04% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
-
Galenica AG Return on Capital Employed (ROCE) for the year ending December 31, 2023 was 9.19%, a -14.12% change year over year.
-
Galenica AG Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 10.70%, a 3.40% change year over year.
-
Galenica AG Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 10.35%, a -15.35% change year over year.
-
Galenica AG Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 12.23%, a 23.54% change year over year.
StockViz
Competitors
Merck & Co., Inc.
USD 81.75
MRK
-0.88
-1.06%
McKesson Corporation
USD 714.92
MCK
+2.77
0.39%
Elevance Health Inc.
USD 293.55
ELV
+4.82
1.67%
Cencora, Inc.
USD 291.80
COR
+2.03
0.70%
BeOne Medicines Ltd.
USD 299.94
ONC
-5.80
-1.90%
JD Health International Inc.
USD 6.44
6618.HK
+0.04
0.61%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.49
2196.HK
-0.03
-1.00%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.61
2607.HK
-0.03
-1.70%
Haisco Pharmaceutical Group Co., Ltd.
USD 7.74
002653.SZ
+0.50
6.87%
Sinopharm Group Co. Ltd.
USD 2.42
1099.HK
-0.08
-3.35%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.32
0874.HK
-0.01
-0.64%
Hikma Pharmaceuticals PLC
USD 26.40
HIK.L
+0.04
0.14%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.05
600079.SS
-0.01
-0.18%
Option Care Health, Inc.
USD 30.64
OPCH
+0.51
1.69%
China Resources Pharmaceutical Group Limited
USD 0.70
3320.HK
-0.01
-1.94%
Key Data
| Date | Return on Capital Employed (ROCE) | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share |
|---|
Competitors
Merck & Co., Inc.
USD 81.75
MRK
-0.88
-1.06%
McKesson Corporation
USD 714.92
MCK
+2.77
0.39%
Elevance Health Inc.
USD 293.55
ELV
+4.82
1.67%
Cencora, Inc.
USD 291.80
COR
+2.03
0.70%
BeOne Medicines Ltd.
USD 299.94
ONC
-5.80
-1.90%
JD Health International Inc.
USD 6.44
6618.HK
+0.04
0.61%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.49
2196.HK
-0.03
-1.00%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.61
2607.HK
-0.03
-1.70%
Haisco Pharmaceutical Group Co., Ltd.
USD 7.74
002653.SZ
+0.50
6.87%
Sinopharm Group Co. Ltd.
USD 2.42
1099.HK
-0.08
-3.35%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.32
0874.HK
-0.01
-0.64%
Hikma Pharmaceuticals PLC
USD 26.40
HIK.L
+0.04
0.14%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.05
600079.SS
-0.01
-0.18%
Option Care Health, Inc.
USD 30.64
OPCH
+0.51
1.69%
China Resources Pharmaceutical Group Limited
USD 0.70
3320.HK
-0.01
-1.94%